Vasorelaxant Effect of Alkaloid N-deacetyllappaconitine on Vascular Smooth Muscle
DOI:
https://doi.org/10.48048/tis.2027.13820Keywords:
Alkaloid, Aorta, Endothelium, Ion channels, Smooth muscle, VasorelaxantAbstract
In the pathogenesis of cardiovascular diseases, disruption of Ca²⁺ homeostasis in vascular smooth muscle cells and the dysregulation of vasoregulatory mechanisms are considered decisive factors. In particular, dysfunction of the Ca²⁺ transport systems in the plasma membrane and the sarcoplasmic reticulum, and the resulting imbalance of endothelium-dependent vasoactive and regulatory factors, play a crucial role. The aim of this study is to comprehensively assess the mechanisms of the vasorelaxant effects of the alkaloid N-deacetyllappaconitine on rat aortic rings. The isometric contraction force of the aortic rings was recorded using a Grass-Telefactor FT.03 myograph and analysed with the PowerLab data-acquisition software (ADInstruments). The results showed that the N-deacetyllappaconitine alkaloid exerts a dose-dependent vasorelaxant effect on KCl- and PE-induced aortic contractions. N-deacetyllappaconitine alkaloids reduce intracellular Ca²⁺ levels by inhibiting L-type Ca²⁺ channels in the plasma membrane and by attenuating IP₃ receptor activity. Furthermore, by partially activating KATP channels, it causes membrane hyperpolarisation and, by inhibiting the reverse mode of the Na⁺/Ca²⁺ exchange system, slows the influx of Ca²⁺ ions into the cell. Thus, the relaxant effect of the alkaloid N-deacetyllappaconitine on aortic rings is realised through a number of complex mechanisms.
HIGHLIGHTS
- It was established that the vasorelaxant effect of the alkaloid N-deacetyllappaconitine in rat aortic rings is mediated through several complex mechanisms.
- The vasorelaxant effect of the alkaloid N-deacetyllappaconitine is primarily mediated via non-endothelial mechanisms and involves inhibition of Ca²⁺ release through L-type Ca²⁺ channels and IP₃ receptors in the sarcoplasmic reticulum.
- Also, The alkaloid N-deacetyllappaconitine reduces intracellular Ca²⁺ homeostasis by activating the SERCA pump and, to a lesser extent, the KATP channel, as well as inhibiting the reverse mode of the Na⁺/Ca²⁺ exchanger, thereby causing relaxation in vascular smooth muscle.
GRAPHICAL ABSTRACT
Downloads
References
M Di Cesare, P Perel, S Taylor, C Kabudula, H Bixby, TA Gaziano, DV McGhie, J Mwangi, B Pervan, J Narula, D Pineiro and FJ Pinto. The Heart of the World. Global Heart 2024; 19(1), 11.
IZ Zhumaev, SN Boboev, PB Usmanov, SB Qurbonova, SY Rustamov, AT Esimbetov, GS Begdullaeva, AA Zaripov and SM Adizov. Mechanism of positive inotropic effect of Vincanine on cardiac muscle contraction activity. Biomedical and Pharmacology Journal 2022; 15(4), 2309-2316.
AA Zaripov, IZ Jumayev, PB Usmanov, YT Mirzayeva, AT Esimbetov, SY Rustamov, SNU Boboev, EBU Ibragimov, SB Qurbonova and SN Zhurakulov. Protective effect of DHQ-11 against hypoxia-induced vasorelaxation. Trends in Sciences 2024; 21(11), 8192.
AV Poznyak, NK Sadykhov, AG Kartuesov, EE Borisov, AA Melnichenko, AV Grechko and AN Orekhov. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Frontiers in Cardiovascular Medicine 2022; 9, 959285.
NR Tykocki, EM Boerman and WF Jackson. Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Comprehensive Physiology 2017; 7(2), 485-581.
A Grego, C Fernandes, I Fonseca, M Dias-Neto, R Costa, A Leite-Moreira, SM Oliveira, F Trindade and R Nogueira-Ferreira. Endothelial dysfunction in cardiovascular diseases: Mechanisms and in vitro models. Molecular and Cellular Biochemistry 2023; 480(8), 4671-4695.
YI Oshchepkova, VV Uzbekov, IZ Jumayev, SY Rustamov, PB Usmanov and SI Salikhov. Antiarrhythmic activity of Ethacizine Hydrochloride and its supramolecular complexes with glycyrrhizic acid and its monoammonium salt. Pharmaceutical Chemistry Journal 2025; 59(6), 657-662.
S Đurašević, M Zdravković, V Nikolić and Z Todorović. Potential new drug targets modulating the environmentally-induced oxidative stress in the cardiovascular system. In: DM Djuric and DK Agrawal (Eds.). Environmental factors in the pathogenesis of cardiovascular diseases. Advances in Biochemistry in Health and Disease. Springer, Cham, Switzerland, 2024, p. 415-432.
CC Hong. The grand challenge of discovering new cardiovascular drugs. Frontiers in Drug Discovery 2022; 2, 1027401.
EJ Vance, MA Rossi, P Sharma and K Tanaka. Therapeutic potential of plant-derived bioactive compounds in gastrointestinal disorders and cardiovascular health. World Journal of Pharmacy and Pharmaceutical Sciences 2025; 3(10), 352-363.
P Ansari, AD Reberio, NJ Ansari, S Kumar, JT Khan, S Chowdhury, FM Abd El-Mordy, JMA Hannan, PR Flatt, YHA Abdel-Wahab and V Seidel. Therapeutic potential of medicinal plants and their phytoconstituents in diabetes, cancer, infections, cardiovascular diseases, inflammation and gastrointestinal disorders. Biomedicines 2025; 13(2), 454.
VV Uzbekov, BF Abdullaev, IZ Jumayev, YI Oshchepkova, PB Usmanov and SI Salikhov. Comparative study of the antiarrhythmic activity of liposomal forms of lappaconitine hydrobromide and its complex with glycyrrhizic acid monoammonium salt in the aconitine arrhythmia model. Pharmaceutical Chemistry Journal 2023; 56(10), 1327-1332.
SK Daley and GA Cordell. Alkaloids in contemporary drug discovery to meet global disease needs. Molecules 2021; 26(13), 3800.
AK Prajapati and G Shah. Alkaloids and their mechanisms of action in cardiovascular diseases. International Journal of Drug Discovery and Pharmacology 2025; 4(3), 100017.
SS Khushmatov, IZ Zhumaev, SN Zhurakulov, AS Saidov and VI Vinogradova. Synthesis and comparative inotropic effects of several isoquinoline alkaloids. Pharmaceutical Chemistry Journal 2020; 54(1), 7-11.
YI Oshchepkova, VV Uzbekov, IZ Jumayev, SY Rustamov, PB Usmanov and SI Salikhov. Antiarrhythmic activity of Ethacizine Hydrochloride and its supramolecular complexes with glycyrrhizic acid and its monoammonium salt. Pharmaceutical Chemistry Journal 2025; 59(6), 657-662.
WF Jackson. Calcium-dependent ion channels and the regulation of arteriolar myogenic tone. Frontiers in Physiology 2021; 12, 770450.
Y Ding and ND Vaziri. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 1998; 32(4), 718-723.
YT Mirzayeva, AA Zaripov, IZ Zhumaev, PB Usmanov, SY Rustamov and SN Boboev. The protective effect of indole alkaloid vincanine against hypoxia-induced vasorelaxation model of rat aorta. Biomedical and Pharmacology Journal 2024; 17(1), 483-491.
IZ Zhumaev, SN Boboev, PB Usmanov, SB Qurbonova, SY Rustamov and AT Esimbetov. Mechanism of positive inotropic effect of Vincanine on cardiac muscle contraction activity. Biomedical and Pharmacology Journal 2022; 15(4), 2309-2316.
MS Yunusov. Antiarrhythmic agents based on diterpenoid alkaloids. Russian Chemical Bulletin 2011; 60(4), 633-638.
Y Shen, WJ Liang, YN Shi and EJ Kennelly. Structural diversity, bioactivities, and biosynthesis of natural diterpenoid alkaloids. Natural Product Reports 2020; 37(6), 763-796.
C Vandier, JY Le Guennec and G Bedfer. What are the signaling pathways used by norepinephrine to contract the artery? A demonstration using guinea pig aortic ring segments. Advances in Physiology Education 2002; 26(3), 195-203.
S Omonturdiev, I Abdullaev, A Khasanov, A Abdullaev, D Inomjanov, U Gayibov, S Gayibova, K Baratov, Y Mirzaeva, M Allamuratov, P Usmanov and T Aripov. Molecular mechanisms and experimental protocols in the study of vasorelaxant activity in aortic smooth muscle cells. Trends in Sciences 2025; 23(2), 11549.
EB Ibragimov, IZ Zhumaev, AA Zaripov, PB Usmanov, SY Rustamov, AT Esimbetov, SM Adizov and AK Kurbanov. Mechanism of vasorelaxant effect of the indole alkaloid 12-hydroxynorfluorocurarine hydrochloride on aortic smooth muscle contraction. Journal of Applied Pharmaceutical Science 2026; 16(3), 283-291.
Y Mirzayeva, I Abdullaev, U Gayibov, S Omonturdiev, Z Allaniyazova, S Umrkulova and P Usmanov. In vitro and computational evaluation of 1-o-benzoylkarakoline on vascular calcium transport. Trends in Sciences 2026; 23(3), 11850.
O Sirojiddin, I Abdullaev, U Gayibov, S Omonturdiev, Z Allaniyazova, S Umrkulova and P Usmanov. Cardiovascular effects of Matricaria chamomilla extract: Calcium channel modulation and vasorelaxant activity. The Science of Nature 2026; 113, 14.
NR Tykocki, WF Jackson and SW Watts. Reverse-mode Na+/Ca2+ exchange is an important mediator of venous contraction. Pharmacological Research 2012; 66(6), 544-554.
ZF Ziyavitdinov, UZ Ishimov, NS Berdiev, IZ Jumayev, YuI Oshchepkova, PB Usmanov and SI Salikhov. Supramolecular complex of lappaconitine hydrobromide and the monoammonium salt of glycyrrhizic acid: Synthesis, physicochemical characteristics, and antiarrhythmic activity. Pharmaceutical Chemistry Journal 2022; 56(2), 167-173.
VV Matchkov, AK Hansen and C Aalkjaer. Na+/K+-pump modulates intercellular communication via interaction with other membrane transporters in vascular smooth muscle cells. The FASEB Journal 2007; 21(6), A912.
PB Usmanov, IZ Jumayev, ShYu Rustamov, AA Zaripov, AT Esimbetov, SN Zhurakulov and VI Vinogradova. The combined inotropic and vasorelaxant effect of DHQ-11, a conjugate of flavonoid dihydroquercetin with isoquinoline alkaloid 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline. Biomedical & Pharmacology Journal 2021; 14(2), 651-661.
C Dai and RA Khalil. Calcium signaling dynamics in vascular cells and their dysregulation in vascular disease. Biomolecules 2025; 15(6), 892.
MF Yam, CS Tan and R Shibao. Vasorelaxant effect of sinensetin via the NO/sGC/cGMP pathway and potassium and calcium channels. Hypertension Research 2018; 41(5), 371-380.
AA Zaripov, IZ Zhumaev, PB Usmanov, YT Mirzaeva, ShY Rustamov, SN Boboev, AT Esimbetov, GS Begdullaeva, SB Sobirov, EB Ibragimov, SN Zhurakulov, DD Safarova and R Yusupova. Mechanism of vasorelaxant action of isoquinoline alkaloid F-19 on rat aorta. Biomedical and Pharmacology Journal 2025; 18(2), 1580-1589.
I Jumayev, P Usmanov, S Rustamov and S Zhurakulov. Comparative inotropic effects of the some isoquinoline alkaloids. Biomedical and Pharmacology Journal 2020; 13(1), 325-333.
A Sandoo, JJ van Zanten, GS Metsios, D Carroll and GD Kitas. The endothelium and its role in regulating vascular tone. The Open Cardiovascular Medicine Journal 2010; 4, 302-312.
E Palma, C Muscoli, S Rubattu, M Volterrani, M Federici, M Volpe and Corporate Author. The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension. Frontiers in Cardiovascular Medicine 2024; 11, 1345218.
T Liu, H Schroeder, GG Power and AB Blood. A physiologically relevant role for NO stored in vascular smooth muscle cells: A novel theory of vascular NO signaling. Redox Biology 2022; 53, 102327.
GC Amberg and MF Navedo. Calcium dynamics in vascular smooth muscle. Microcirculation 2013; 20(4), 281-289.
R Bagur and G Hajnóczky. Intracellular Ca2+ sensing: Its role in calcium homeostasis and signaling. Molecular Cell 2017; 66(6), 780-788.
EA Pereira da Silva, M Martín-Aragón Baudel, MF Navedo and M Nieves-Cintrón. Ion channel molecular complexes in vascular smooth muscle. Frontiers in Physiology 2022; 13, 999369.
S Zhang, JX Yuan, KE Barrett and H Dong. Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells. American Journal of Physiology: Cell Physiology 2005; 288(2), C245-C252.
MJ Shattock, M Ottolia, DM Bers, MP Blaustein, A Boguslavskyi, J Bossuyt, JH Bridge, Y Chen-Izu, CE Clancy, A Edwards, J Goldhaber, J Kaplan, JB Lingrel, D Pavlovic, K Philipson, KR Sipido and ZJ Xie. Na+/Ca2+ exchange and Na+/K+-ATPase in the heart. Journal of Physiology 2015; 593(6), 1361-1382.
SB Qurbonova, IZ Zhumaev, SN Boboev, PB Usmanov, SY Rustamov, AA Zaripov and ShN Zhurakulov. Antiarrhythmic effect of 1-(3'-bromophenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline hydrochloride. Biomedical and Pharmacology Journal 2025; 18(3), 2463-2473.
L Zhang, C Staehr, F Zeng, EV Bouzinova and VV Matchkov. The Na,K-ATPase in vascular smooth muscle cells. Current Topics in Membranes 2019; 83, 151-175.
JP Johny, MJ Plank and T David. Importance of altered levels of SERCA, IP3R, and RyR in vascular smooth muscle cell. Biophysical Journal 2017; 112(2), 265-287.
S Wray and T Burdyga. Sarcoplasmic reticulum function in smooth muscle. Physiological Reviews 2010; 90(1), 113-178.
FV Brozovich, CJ Nicholson, CV Degen, YZ Gao, M Aggarwal and KG Morgan. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacological Reviews 2016; 68(2), 476-532.
G Mirzaalimova, A Zaynabiddinov, S Omonturdiev, D Inomjanov, I Abdullaev, U Gayibov and M Kholmirzayeva. In silico and in vitro activity of Leonurus turkestanicus on the aortic smooth muscle ion channels. Trends in Sciences 2026; 23(5), 12146.
S Kobayashi, AV Somlyo and AP Somlyo. Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochemical and Biophysical Research Communications 1988; 153(2), 625-631.
H Yamamoto, H Kanaide and M Nakamura. Heparin specifically inhibits the inositol 1, 4, 5-trisphosphate-induced Ca2+ release from skinned rat aortic smooth muscle cells in primary culture. Naunyn-Schmiedeberg's Archives of Pharmacology 1990; 341(4), 273-278.
M Kaßmann, IA Szijártó, CF García-Prieto and G Fan. Role of ryanodine type 2 receptors in elementary Ca2+ signaling in arteries and vascular adaptive responses. Journal of the American Heart Association 2019; 8(9), e010090.
SN Boboev, IZ Zhumaev, PB Usmanov, AA Zaripov, SY Rustamov, ShB Qurbonova, EB Ibragimov, SB Sobirov and SN Zhurakulov. Role of F-4 isoquinoline alkaloid, dihydroquercetin flavonoid and conjugate DKV-6 in myocardial RyR2 and SERCA2a under normal and hypoxic conditions. Biomedical & Pharmacology Journal 2026; 19(1), 578-591.
KD Wu, D Bungard and J Lytton. Regulation of SERCA Ca2+ pump expression by cytoplasmic Ca2+ in vascular smooth muscle cells. American Journal of Physiology: Cell Physiology 2001; 280(4), C843-C851.
Q Yu and W Tian. The role of SERCA in vascular diseases, a potential therapeutic target. Cell Calcium 2025; 129, 103039.
IZ Zhumaev, SNU Boboev, PB Usmanov, SY Rustamov, AA Zaripov, SB Qurbonova, SY Rustamov, EBU Ibragimov, AA Zaripov and SM Adizov. Role of RyR2 and SERCA2a in the cardioprotective effects of vincanine and pyrazoline alkaloids. Trends in Sciences 2025; 22(1), 8626.
LY Zhang, XY Chen, H Dong and F Xu. Cyclopiazonic acid-induced Ca2+ store depletion initiates endothelium-dependent hyperpolarization-mediated vasorelaxation of mesenteric arteries in healthy and colitis mice. Frontiers in Physiology 2021; 12, 648950.
C Selli and M Tosun. Effects of cyclopiazonic acid and dexamethasone on serotonin-induced calcium responses in vascular smooth muscle cells. Journal of Physiology and Biochemistry 2016; 72(2), 245-253.
WF Jackson. Potassium channels in regulation of vascular smooth muscle contraction and growth. Advances in Pharmacology 2017; 78, 89-144.
MF Dogan, O Yildiz, SO Arslan and KG Ulusoy. Potassium channels in vascular smooth muscle: A pathophysiological and pharmacological perspective. Fundamental & Clinical Pharmacology 2019; 33(5), 504-523.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Walailak University

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.



